FDA Inspection 1250223 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on Sep 18, 2024 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 18, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)